Currently out of the existing stock ratings of Ross Muken, 83 are a BUY (60.58%), 5 are a SELL (3.65%), 49 are a HOLD (35.77%).

Ross Muken

Work Performance Price Targets & Ratings Chart

Analyst Ross Muken, currently employed at EVERCORE, carries an average stock price target met ratio of 86.11% that have a potential upside of 17.27% achieved within 561 days.

Ross Muken’s has documented 276 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on CRL, Charles River Laboratories at 25-Sep-2026.

Wall Street Analyst Ross Muken

Analyst best performing recommendations are on RAD (RITE AID).
The best stock recommendation documented was for PDCO (PATTERSON COMPANIES) at 6/21/2018. The price target of $18.5 was fulfilled within 1 day with a profit of $0.73 (4.11%) receiving and performance score of 41.08.

Average potential price target upside

DGX Quest Diagnostics ICLR ICON PLC MCK McKesson PDCO Patterson Companies RAD Rite Aid A Agilent Technologies ABC AmerisourceBergen ATHN athenahealth CAH Cardinal Health HSIC Henry Schein WBA Walgreens Boots Alliance CERN Cerner Corp ILMN Illumina IQV IQVIA Holdings LH Laboratory of America Holdings Q Quintiles Transnational QGEN Qiagen NV TMO Thermo Fisher Scientific TWST Twist Bioscience Corp EHTH eHealth CRL Charles River Laboratories CVS CVS Health Corp DHR Danaher MDRX Allscripts Healthcare Solutions PINC Premier WAT Waters ONVO Organovo Holdings BRKR Bruker MTD Mettler-Toledo International COR Cencora RVTY Revvity

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 02-Feb-2018

$260

$26.67 (11.43%)

$250

16 days ago
(21-Sep-2026)

21/23 (91.3%)

$15.12 (6.17%)

347

Hold Since 22-Apr-2022

$245

$11.67 (5.00%)

$220

29 days ago
(08-Sep-2026)

21/21 (100%)

$9.5 (4.03%)

268

Hold Since 30-May-2024

$250

$16.67 (7.14%)

$190

2 months 9 days ago
(28-Jul-2026)

3/4 (75%)

$14.06 (5.96%)

213

Buy Since 22-Apr-2026

$250

$16.67 (7.14%)

$230

2 months 13 days ago
(24-Jul-2026)

2/3 (66.67%)

$22.14 (9.72%)

62

Buy Since 26-Apr-2017

$260

$26.67 (11.43%)

$235

2 months 13 days ago
(24-Jul-2026)

28/29 (96.55%)

$32.14 (14.11%)

553

Show more analysts

Please expand the browser size to see the chart

Which stock is Ross Muken most bullish on?

Potential upside of $39.81 has been obtained for CRL (CHARLES RIVER LABORATORIES)

Which stock is Ross Muken most reserved on?

Potential downside of $17.95 has been obtained for ICLR (ICON PLC)

What Year was the first public recommendation made by Ross Muken?

On 2012
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?